Drug Shortage Report for NOZINAN
Report ID | 164430 |
Drug Identification Number | 01927698 |
Brand name | NOZINAN INJ 25MG/ML |
Common or Proper name | Nozinan |
Company Name | NEURAXPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | METHOTRIMEPRAZINE |
Strength(s) | 25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 10 |
ATC code | N05AA |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-07-25 |
Actual start date | 2022-07-18 |
Estimated end date | 2022-12-19 |
Actual end date | 2022-12-15 |
Shortage status | Resolved |
Updated date | 2022-12-19 |
Company comments | Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ELISABETH-SELBERT-STR. 23 LANGENFELD, GERMANY 40764 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2022-12-19 | English | Compare |
v13 | 2022-11-30 | French | Compare |
v12 | 2022-11-30 | English | Compare |
v11 | 2022-08-16 | French | Compare |
v10 | 2022-08-16 | English | Compare |
v9 | 2022-07-19 | English | Compare |
v8 | 2022-07-18 | French | Compare |
v7 | 2022-07-18 | English | Compare |
v6 | 2022-07-12 | French | Compare |
v5 | 2022-07-12 | English | Compare |
v4 | 2022-07-11 | French | Compare |
v3 | 2022-07-11 | English | Compare |
v2 | 2022-07-11 | French | Compare |
v1 | 2022-07-11 | English | Compare |
Showing 1 to 14 of 14